Jazz Pharmaceuticals (JAZZ) Treasury Shares (2012 - 2025)

Jazz Pharmaceuticals' Treasury Shares history runs 14 years deep, the most recent figure standing at $4.4 million for Q4 2025.

• On a quarterly basis, Treasury Shares rose 9.25% year-over-year to $4.4 million in Q4 2025; TTM through Dec 2025 was $4.4 million, a 9.25% increase from a year earlier, with the FY2025 full-year figure at $4.4 million, up 9.25% from the prior year.
• Treasury Shares advanced to $4.4 million in Q4 2025 per JAZZ's latest filing, from $4.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $4.4 million in Q4 2025 and bottomed at $2.6 million in Q4 2021.
• The 5-year median for Treasury Shares is $3.6 million (2023), against an average of $3.6 million.
• Across the five-year window, Treasury Shares jumped 40.1% in 2021 and rose 9.25% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $2.6 million in 2021, then gained by 21.97% to $3.2 million in 2022, then grew by 11.03% to $3.6 million in 2023, then climbed by 13.19% to $4.0 million in 2024, then increased by 9.25% to $4.4 million in 2025.
• Per Business Quant, the three latest JAZZ Treasury Shares figures stand at $4.4 million (Q4 2025), $4.0 million (Q4 2024), and $3.6 million (Q4 2023).